Clinical

Dataset Information

0

A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies


ABSTRACT: STUDY OBJECTIVES 1. The primary objective of this protocol is to determine the safety of immunization with CEA(6D) VRP in patients with advanced or metastatic CEA expressing malignancies. 2. The secondary objectives are to evaluate CEA-specific immune response to the immunizations and obtain preliminary data on response rate.

DISEASE(S): Lung Cancer,Colon Cancer,Colorectal Cancer,Pancreatic Cancer,Breast Cancer,Neoplasms,Colonic Neoplasms

PROVIDER: 2044252 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2015-08-27 | E-GEOD-72398 | biostudies-arrayexpress
2023-02-03 | GSE213828 | GEO
| 2285031 | ecrin-mdr-crc
| 2221147 | ecrin-mdr-crc
2020-10-29 | GSE155887 | GEO
| S-EPMC3944709 | biostudies-literature
2020-04-06 | GSE121888 | GEO
2013-07-20 | E-GEOD-49040 | biostudies-arrayexpress
| 2336180 | ecrin-mdr-crc
2020-09-05 | GSE157021 | GEO